Effects of the pre-existing coronary heart disease on the prognosis of COVID-19 patients: A systematic review and meta-analysis

被引:2
|
作者
Wang, Saikun [1 ]
Zhu, Ruiting [1 ]
Zhang, Chengwei [2 ]
Guo, Yingze [1 ]
Lv, Mengjiao [1 ]
Zhang, Changyue [1 ]
Bian, Ce [1 ]
Jiang, Ruixue [1 ]
Zhou, Wei [3 ]
Guo, Lirong [1 ]
机构
[1] Jilin Univ, Sch Nursing, Changchun, Jilin, Peoples R China
[2] Second Hosp Jilin Univ, Dept Anesthesiol, Changchun, Jilin, Peoples R China
[3] First Hosp Jilin Univ, Changchun, Jilin, Peoples R China
来源
PLOS ONE | 2023年 / 18卷 / 10期
关键词
CRITICALLY-ILL PATIENTS; CLINICAL CHARACTERISTICS; MYOCARDIAL INJURY; CRITICAL ILLNESS; MORTALITY; SEVERITY; OUTCOMES; DEATH; PREDICTORS; SARS-COV-2;
D O I
10.1371/journal.pone.0292021
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Although studies have shown severe Coronavirus disease 2019 (COVID-19) outcomes in patients with pre-existing coronary heart disease (CHD), the prognosis of COVID-19 patients with pre-existing CHD remains uncertain primarily due to the limited number of patients in existing studies. This study aimed to investigate the impacts of pre-existing CHD on the prognosis of COVID-19 patients. Five electronic databases were searched for eligible studies. This article focused on cohort and case-control studies involving the prognosis of COVID-19 patients with pre-existing CHD. The meta-analysis was performed using a random effects model. The odds ratios (ORs) and 95% confidence intervals (CIs) were used as valid indicators. The study was registered in PROSPERO with the identifier: CRD42022352853. A total of 81 studies, involving 157,439 COVID-19 patients, were included. The results showed that COVID-19 patients with pre-existing CHD exhibited an elevated risk of mortality (OR = 2.45; 95%CI: [2.04, 2.94], P < 0.001), severe/critical COVID-19 (OR = 2.57; 95%CI: [1.98, 3.33], P < 0.001), Intensive Care Unit or Coronary Care Unit (ICU/CCU) admission: (OR = 2.75, 95%CI: [1.61, 4.72], P = 0.002), and reduced odds of discharge/recovery (OR = 0.43, 95%CI: [0.28, 0.66], P < 0.001) compared to COVID-19 patients without pre-existing CHD. Subgroup analyses indicated that the prognosis of COVID-19 patients with pre-existing CHD was influenced by publication year, follow-up duration, gender, and hypertension. In conclusion, pre-existing CHD significantly increases the risk of poor prognosis in patients with COVID-19, particularly in those male or hypertensive patients.
引用
收藏
页数:22
相关论文
共 50 条
  • [41] Coagulopathy in patients with COVID-19: a systematic review and meta-analysis
    Zhang, Xiaolin
    Yang, Xue
    Jiao, Hongmei
    Liu, Xinmin
    AGING-US, 2020, 12 (24): : 24535 - 24551
  • [42] Alopecia in COVID-19 patients: Systematic review and meta-analysis
    Nguyen, Betty
    Tosti, Antonella
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB15 - AB15
  • [43] Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence
    Marina Treskova-Schwarzbach
    Laura Haas
    Sarah Reda
    Antonia Pilic
    Anna Borodova
    Kasra Karimi
    Judith Koch
    Teresa Nygren
    Stefan Scholz
    Viktoria Schönfeld
    Sabine Vygen-Bonnet
    Ole Wichmann
    Thomas Harder
    BMC Medicine, 19
  • [44] Azithromycin in patients with COVID-19: a systematic review and meta-analysis
    Ayerbe, Luis
    Risco-Risco, Carlos
    Forgnone, Ivo
    Perez-Pinar, Maria
    Ayis, Salma
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (02) : 303 - 309
  • [45] Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis
    Singh, Awadhesh Kumar
    Singh, Akriti
    Singh, Ritu
    Misra, Anoop
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (04) : 589 - 596
  • [46] Obesity in patients with COVID-19: a systematic review and meta-analysis
    Huang, Yi
    Lu, Yao
    Huang, Yan-Mei
    Wang, Min
    Ling, Wei
    Sui, Yi
    Zhao, Hai-Lu
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2020, 113
  • [47] ECMO in COVID-19 Patients: A Systematic Review and Meta-analysis
    Bertini, Pietro
    Guarracino, Fabio
    Falcone, Marco
    Nardelli, Pasquale
    Landoni, Giovanni
    Nocci, Matteo
    Paternoster, Gianluca
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2022, 36 (08) : 2700 - 2706
  • [48] Metformin in Patients With COVID-19: A Systematic Review and Meta-Analysis
    Li, Yin
    Yang, Xue
    Yan, Peijing
    Sun, Tong
    Zeng, Zhi
    Li, Sheyu
    FRONTIERS IN MEDICINE, 2021, 8
  • [49] Prevalence and prognosis of increased pancreatic enzymes in patients with COVID-19: A systematic review and meta-analysis
    Yang, Feng
    Xu, Yecheng
    Dong, Yinlei
    Huang, Yuting
    Fu, Yunting
    Li, Tian
    Sun, Chenyu
    Pandanaboyana, Sanjay
    Windsor, John A.
    Fu, Deliang
    PANCREATOLOGY, 2022, 22 (04) : 539 - 546
  • [50] Prognosis of COVID-19 in Patients with Liver and Kidney Diseases: An Early Systematic Review and Meta-Analysis
    Oyelade, Tope
    Alqahtani, Jaber
    Canciani, Gabriele
    TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2020, 5 (02)